The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)

Journal of the American College of Cardiology

Volumn 43, Issue 6, 2004, Pages 1110-1115

  Schampaert, Erick ^a   Cohen, Eric A ^b   Schlüter, Michael ^c   Reeves, François ^d   Traboulsi, Mouhieddin ^e   Title, Lawrence M ^f   Kuntz, Richard E ^g   Popma, Jeffrey J ^g  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c Ctr Cardiol and Vasc Intervention   (Germany)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e Calgary Learning Centre   (Canada)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bare metal stent; BMS; In stent restenosis; ISR; MACE; Major adverse cardiac events; Minimal lumen diameter; MLD; PCI; Percutaneous coronary intervention; QCA; Quantitative coronary angiography; SES; Sirolimus eluting stent; Target lesion revascularization; TLR

Indexed keywords

RAPAMYCIN;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY STENT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MALE; MEDICAL ASSESSMENT; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVIEW;

EID: 1542708491     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.01.024     Document Type: Article

References (18)

1. Fischman D.L., Leon M.B., Baim D.S., et al. for the Stent Restenosis Study Investigators. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
2. Serruys P.W., de Jaegere P., Kiemeneij F., et al. for the Benestent Study Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
3. Al Suwaidi J., Berger P.B., Holmes D.R. Jr. Coronary artery stents. JAMA. 284:2000;1828-1836.
4. Kastrati A., Schömig A., Dietz R., Neumann F.J., Richardt G. Time course of restenosis during the first year after emergency coronary stenting. Circulation. 87:1993;1498-1505.
5. Gordon P.C., Gibson C.M., Cohen D.J., Carrozza J.P., Kuntz R.E., Baim D.S. Mechanism of restenosis and redilatation within coronary stents quantitative angiographic assessment. J Am Coll Cardiol. 21:1993;1166-1174.
6. Kornowski R., Hong M.K., Tio F.O., Bramwell O., Wu H., Leon M.B. In-stent restenosis contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 31:1998;224-230.
7. Hoffmann R., Mintz G.S., Dussaillant G.R., et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation. 94:1996;1247-1254.
8. Kastrati A., Schömig A., Elezi S., et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 30:1997;1428-1436.
9. Bauters C., Hubert E., Prat A., et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol. 31:1998;1291-1298.
10. Leon M.B., Teirstein P.S., Moses J.W., et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 344:2001;250-256.
11. Sousa J.E., Serruys P.W., Costa M.A. New frontiers in cardiology drug-eluting stents: part II. Circulation. 107:2003;2383-2389.
12. Gallo R., Padurean A., Jayaraman T., et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation. 99:1999;2164-2170.
13. Suzuki T., Kopia G., Hayashi S., et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation. 104:2001;1188-1193.
14. Marx S.O., Marks A.R. Bench to bedside the development of rapamycin and its application to stent restenosis. Circulation. 104:2001;852-855.
15. Sousa J.E., Costa M.A., Abizaid A.C., et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents one-year angiographic and intravascular ultrasound follow-up. Circulation. 104:2001;2007-2011.
16. Morice M.C., Serruys P.W., Sousa J.E., et al. for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 346:2002;1773-1780.
17. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 349:2003;1315-1323.
18. Schofer J., Schlüter M., Gershlick A.H., et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries double-blind, randomized controlled trial (E-SIRIUS). Lancet. 362:2003;1093-1099.